

| Catalog No. | HP136014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Species reactivity | Human | ||||||||
| Applications | ELISA, IHC, WB | ||||||||
| Host species | Rabbit | ||||||||
| Isotype | IgG | ||||||||
| Clonality | Polyclonal | ||||||||
| Immunogen | E. coli - derived recombinant Human GPR35 (Arg240-Ala309). | ||||||||
| Target | KYNA receptor, Kynurenic acid receptor, GPR35, G-protein coupled receptor 35 | ||||||||
| Purification | Purified by antigen affinity column. | ||||||||
| Accession | Q9HC97 | ||||||||
| Form | Liquid | ||||||||
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||||||
| Product Usage Information |
| ||||||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||||||
| Background | G-protein coupled receptor 35 (GPR35) is a ~34 kDa protein. G-protein coupled receptor that binds to several ligands including the tryptophan metabolite kynurenic acid (KYNA), lysophosphatidic acid (LPA) or 5-hydroxyindoleacetic acid (5-HIAA) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase. GPR35 can couple with G(i)/G(o)- or G(12)/G(13) classes of G alpha proteins depending on the context, mediating the inhibition of adenylate cyclase or activation Rho small GTPases, respectively. KYNA-binding promotes monocyte adhesion to vascular endothelium under flow conditions, leading to G(i)/GNAI1 activation and inhibition of adenylate cyclase. Involved in cardioprotection during ischemia by promoting mitochondrial remodeling: following KYNA-binding and G(i)/GNAI1 activation, GPR35 is internalized to the outer mitochondrial membrane, where it inhibits mitochondrial adenylate cyclase (ADCY10), allowing ATPIF1 to repress ATP synthase activity. 1. Wang, J. et al. (2006) The Journal of biological chemistry 281, 22021-22028. PMID: 16754668 2. Barth, MC. et al. (2009) The Journal of biological chemistry 284, 19189-95. PMID: 19473985 3. Oka, S. et al. (2010) Biochemical and biophysical research communications 395, 232-7. PMID: 20361937 4. Zhao, P. et al. (2014) The Journal of biological chemistry 289, 3625-38. PMID: 24347166 5. De Giovanni, M. et al. (2022) Cell 185, 815-830.e19. PMID: 35148838 6. Wyant, GA. et al. (2022) Science (New York, N.Y.) 377, 621-629. PMID: 35926043 | ||||||||
| Note | For research use only. |
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский